Astrana Health
ASTH
36 hedge funds and large institutions have $50.4M invested in Astrana Health in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
13% more funds holding
Funds holding: 32 → 36 (+4)
1.02% less ownership
Funds ownership: 7.83% → 6.81% (-1%)
25% less capital invested
Capital invested by funds: $67.5M → $50.4M (-$17.1M)
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.01M |
| 3 |
RA
Royce & Associates
New York
|
+$1.81M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$1.54M |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$16.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$3.56M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$3.23M |
| 4 |
Morgan Stanley
New York
|
-$962K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$701K |
ASTH Hedge Fund Activity: Q3 2018 in Review
36 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q3 2018, worth a combined $50.4M — down 25% from $67.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ASTH positions and 5 closed out — a net gain of 4 holders — while 7 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $12.7M. The largest seller was BlackRock, cutting an estimated $16.2M.
- 36 institutional investors held Astrana Health (ASTH) as of Q3 2018, up from 32 in Q2 2018.
- Funds reported $50.4M of Astrana Health stock for Q3 2018, down 25% quarter-over-quarter.
- 9 funds opened new Astrana Health positions in Q3 2018 and 5 closed out, a net change of +4 holders.
- The largest Astrana Health buyer in Q3 2018 was Vanguard Group, an estimated $12.7M added.
- The largest Astrana Health seller in Q3 2018 was BlackRock, an estimated $16.2M sold.
Based on aggregated 13F filings for Q3 2018.